Save your place

Sign in to WhoBought

Please try again later.

Jeremy Grantham's Larimar Therapeutics, Inc. (LRMR) position

Yes: as of Q1 2026, Jeremy Grantham holds 13K shares of LRMR worth an amount we cannot price (0.0% of the disclosed portfolio). Last quarter the position was opened. First disclosed Q1 2026.
View full portfolio →
Current value
an amount we cannot price
Shares held
13K
% of portfolio
0.0%
Quarter-end price
No quarter-end price available

Average buy price is hidden here because at least one covered purchase quarter has no usable local mean price.

LRMR price vs Grantham's position

Dates
Average closing price · filing quarter
Price range · filing quarter

Every quarterly change

Quarter Action Shares change Est. value change Δ Own Shares held Filing date
Q1 2026 New +13K 13K May 14, 2026
Data through Q1 2026 · filed May 14, 2026
1 grouped rows from 1 quarters

More Grantham positions

Common questions

Does Jeremy Grantham own LRMR?

Yes. As of Q1 2026, Jeremy Grantham disclosed 13K shares of LRMR, worth an amount we cannot price. All figures come from SEC 13F filings for Q1 2026, the latest disclosed quarter.

When did Jeremy Grantham buy LRMR?

Jeremy Grantham first disclosed a LRMR position in Q1 2026; every quarterly buy and sell since is in the table above. All figures come from SEC 13F filings for Q1 2026, the latest disclosed quarter.

Did Jeremy Grantham sell LRMR?

The quarter-by-quarter table above shows each sale and reduction Jeremy Grantham disclosed in LRMR. All figures come from SEC 13F filings for Q1 2026, the latest disclosed quarter.

How many shares of LRMR does Jeremy Grantham own?

Jeremy Grantham disclosed 13K shares of LRMR as of Q1 2026. All figures come from SEC 13F filings for Q1 2026, the latest disclosed quarter.

What price did Jeremy Grantham pay for LRMR?

Jeremy Grantham began building the LRMR position before our 13F history starts, so an exact average buy price cannot be estimated without understating it. All figures come from SEC 13F filings for Q1 2026, the latest disclosed quarter.

How are the estimated trade prices calculated?

13F filings disclose quarter-end holdings, not trade dates or execution prices. These estimates use each covered quarter's average market price; the add average excludes the opening position and quarters without price data. All figures come from SEC 13F filings for Q1 2026, the latest disclosed quarter.